Rebecca Bakker-Arkema
Keine laufenden Positionen mehr
Profil
Rebecca Bakker-Arkema worked as a Director of Clinical Development at Parke, Davis & Co. LLC, and as a Principal at General Electric Co., Pfizer Inc., The Upjohn Co., and Metabasis Therapeutics, Inc. She also worked as a Professor at the University of Michigan and as a Vice President of Clinical and Drug & Clinical Development at AlphaCore Pharma LLC and Gemphire Therapeutics, Inc.
Ehemalige bekannte Positionen von Rebecca Bakker-Arkema
| Unternehmen | Position | Ende |
|---|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| GE AEROSPACE | Corporate Officer/Principal | - |
| University of Michigan | Corporate Officer/Principal | - |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| GE AEROSPACE | Producer Manufacturing |
| Private Unternehmen | 5 |
|---|---|
AlphaCore Pharma LLC
 AlphaCore Pharma LLC Miscellaneous Commercial ServicesCommercial Services AlphaCore Pharma LLC engages in pharmaceutical research. It develops recombinant human lecithin-cholesterol acyltransferase enzyme that helps reducing cholesterol from the body. The company was founded by Reyn Homan, Bruce J. Auerbach, and Brian R. Krausen on June 20, 2007 and is headquartered in Ann Arbor, MI. | Commercial Services |
| The Upjohn Co. | Health Technology |
| Parke, Davis & Co. LLC | |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Health Technology |
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |
